Dermata Therapeutics Senior Vice President, Chief Development Officer Christopher Nardo's 2023 pay rises 19% to $470K
Dermata Therapeutics reports 2023 executive compensation
By ExecPay News
Published: March 26, 2024
Dermata Therapeutics reported fiscal year 2023 executive compensation information on March 26, 2024.
In 2023, three executives at Dermata Therapeutics received on average a compensation package of $435K, a 2% increase compared to previous year.
Average pay of disclosed executives at Dermata Therapeutics
Christopher J. Nardo, Senior Vice President, Chief Development Officer, received $470K in total, which increased by 19% compared to 2022. 71% of Nardo's compensation, or $336K, was in salary. Nardo also received $108K in bonus and $26K in option awards.
Kyri Van Hoose, Chief Financial Officer, received a compensation package of $442K, which increased by 17% compared to previous year. 71% of the compensation package, or $315K, was in salary.
Gerald T. Proehl, Chief Executive Officer, earned $392K in 2023, a 22% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on March 26, 2024.